Sangart
closedBiopharmaceutical company developing global scientific, clinical and commercial oxygen-therapeutic agents.
Launch date
Employees
Market cap
-
Enterprise valuation
$200—300m (Dealroom.co estimates May 2012.)
San Diego California (HQ)
Authorizing premium user...